Correlation between myelin basic protein levels in cerebrospinal fluid and motor speed in patients with schizophrenia
- PMID: 39133634
- PMCID: PMC11544460
- DOI: 10.1002/npr2.12471
Correlation between myelin basic protein levels in cerebrospinal fluid and motor speed in patients with schizophrenia
Abstract
Alterations in the white matter have been implicated in schizophrenia. Myelin basic protein (MBP), a component of the myelin sheath, in the cerebrospinal fluid (CSF) has been suggested as a biomarker for white matter damage in demyelinating diseases. This prompted us to examine the CSF-MBP levels in patients with schizophrenia. We analyzed the CSF-MBP levels in 152 patients with schizophrenia and 117 age- and sex-matched controls. A significant positive correlation between age and CSF-MBP levels was observed both in the patients (p < 0.001) and controls (p = 0.014). No significant difference was observed in the CSF-MBP levels between the two groups. However, among a subsample of the patients (N = 32), a significantly negative correlation was observed between CSF-MBP and age-adjusted motor speed score of the brief assessment of cognition in schizophrenia (ρ = -0.59, p < 0.001). Further, among patients who underwent diffusional magnetic resonance imaging of the brain (N = 27), the CSF-MBP levels showed a significantly negative correlation with the mean kurtosis value in the right temporo-parietal region (p < 0.001). Our results suggest that the CSF-MBP level has limited utility as a diagnostic marker; however, higher CSF-MBP levels are associated with poorer motor speed, which may be associated with regional white matter damage in the brain in patients with schizophrenia.
Keywords: cerebrospinal fluid; demyelination; motor speed; myelin basic protein; schizophrenia.
© 2024 The Author(s). Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex.J Neuroimmunol. 1992 Feb;36(2-3):251-4. doi: 10.1016/0165-5728(92)90058-s. J Neuroimmunol. 1992. PMID: 1370671
-
Neuron-specific Enolase and myelin basic protein in cerebrospinal fluid of patients with first episode schizophrenia.J Huazhong Univ Sci Technolog Med Sci. 2006;26(2):228-30. doi: 10.1007/BF02895823. J Huazhong Univ Sci Technolog Med Sci. 2006. PMID: 16850754
-
Fractional anisotropy in the centrum semiovale as a quantitative indicator of cerebral white matter damage in the subacute phase in patients with carbon monoxide poisoning: correlation with the concentration of myelin basic protein in cerebrospinal fluid.J Neurol. 2012 Aug;259(8):1698-705. doi: 10.1007/s00415-011-6402-5. Epub 2012 Jan 19. J Neurol. 2012. PMID: 22258479 Free PMC article.
-
Myelin basic protein in cerebrospinal fluid and other body fluids.Mult Scler. 1998 Feb;4(1):16-21. doi: 10.1177/135245859800400105. Mult Scler. 1998. PMID: 9532587 Review.
-
Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.Mol Cell Neurosci. 2021 Oct;116:103670. doi: 10.1016/j.mcn.2021.103670. Epub 2021 Sep 23. Mol Cell Neurosci. 2021. PMID: 34562592 Review.
References
-
- Janoutová J, Janácková P, Serý O, Zeman T, Ambroz P, Kovalová M, et al. Epidemiology and risk factors of schizophrenia. Neuro Endocrinol Lett. 2016;37:1–8. - PubMed
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders: DSM‐5‐TR. Washington, DC: American Psychiatric Association Publishing; 2022.
-
- Walterfang M, McGuire PK, Yung AR, Phillips LJ, Velakoulis D, Wood SJ, et al. White matter volume changes in people who develop psychosis. Br J Psychiatry. 2008;193:210–215. - PubMed
-
- Hulshoff Pol HE, Brans RGH, van Haren NEM, Schnack HG, Langen M, Baaré WFC, et al. Gray and white matter volume abnormalities in monozygotic and same‐gender dizygotic twins discordant for schizophrenia. Biol Psychiatry. 2004;55:126–130. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous